Netherlands· NL-390556491192
Mounjaro 10 mg/dosis KwikPen oplossing voor injectie in voorgevulde pen
A tirzepatide product containing tirzepatide, registered in Netherlands by Eli Lilly Nederland B.V.. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tirzepatide is registered in 15 of 19 countries.
Countries holding a registration under ATC A10BX16 (tirzepatide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Tirzepatide · ATC A10BX16
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tirzepatide costs, country by country.
Normalised to the WHO defined daily dose (1.4 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tirzepatide · price per daily dose (1.4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$45.12
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TIRZEPATIDE
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Netherlands (NL)
- ATC code
- A10BX16
- ATC class
- Tirzepatide
- Defined daily dose
- 1.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/22/1685
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tirzepatide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandMounjaro 10 mg solution for injection in pre-filled penEli Lilly Nederland B.V.
- United StatesMounjaroEli Lilly and Company
- CzechiaMOUNJAROEli Lilly Nederland B.V., Utrecht
- FinlandMounjaroEli Lilly Nederland B.V.
- SwitzerlandMounjaro 10 mg, solution for injection in vialEli Lilly (Suisse) SA
- SpainMOUNJARO 10 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAEli Lilly Nederland B.V.
- BelgiumMounjaro 10 mgEli Lilly Nederland
- IcelandMounjaroEli Lilly Nederland B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mounjaro, Mounjaro Kwikpen
- Liechtenstein · Mounjaro, Mounjaro Kwikpen
- Norway · Mounjaro, Mounjaro Kwikpen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf7c07e0-1ec5-4969-9e6a-a0c927d89fd3 GET /v1/drugs/bf7c07e0-1ec5-4969-9e6a-a0c927d89fd3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/mounjaro-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Tirzepatide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp132443",
"excipients": [
"BENZYLALCOHOL (E 1519)",
"DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339)",
"FENOL",
"GLYCEROL (E 422)",
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"TIRZEPATIDE"
],
"leaflet_url": null,
"authorised_at": "2024/04/19",
"procedure_number": "EMEA/H/C/005620",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/22/1685",
"additional_monitoring": "Y"
}See everything about tirzepatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.